ReproNovo Doses First Participant in Phase 2 Trial of RPN-001, a Novel Oral Therapy for Male Infertility

RPN-001 is a novel orally administered aromatase inhibitor being developed for the treatment of infertility in men with low serum testosterone No FDA-...

July 02, 2025 | Wednesday | News
HUTCHMED and AstraZeneca Secure China Approval for ORPATHYS®–TAGRISSO® Combination in EGFR-Mutant NSCLC with MET Amplification

HUTCHMED (China) Limited  announces that the New Drug Application (“NDA”) for the combination of ORPATHYS® (savolitinib) and TAGRISS...

July 01, 2025 | Tuesday | News
Labviva Launches HarperChem to Transform Chemical Supply Chain with AI-Powered Search and Inventory Management

The life sciences chemical supply chain has traditionally been a bottleneck to R&D innovation, often requiring scientists to stop their research to m...

June 30, 2025 | Monday | News
ProBio Opens Flagship Cell and Gene Therapy Center of Excellence in New Jersey, Advancing Global Biomanufacturing Capabilities

ProBio, a global contract development and manufacturing organization (CDMO) specializing in cell and gene therapy, today announced the opening of its...

June 27, 2025 | Friday | News
Bristol Myers Squibb’s streamlined CAR T therapy labels signal broader patient access and regulatory confidence

Bristol Myers Squibb’s announcement that the US Food and Drug Administration has approved the removal of REMS programs an...

June 27, 2025 | Friday | News
Invetech and AiCella Forge Strategic Alliance to Accelerate AI-Driven Cell Therapy Manufacturing

Invetech, a global leader in solving complex manufacturing and product development challenges in the advanced therapies and diagnostics markets, today an...

June 27, 2025 | Friday | News
Novo Nordisk Partners with WeightWatchers to Expand Access to Wegovy® with New Nationwide Pricing Initiative

Novo Nordisk continues expansion of patient access to Wegovy® (semaglutide) injection 2.4 mg through a new collaboration with WeightWatchers...

June 27, 2025 | Friday | News
Claritev Partners with Fractional AI to Accelerate Responsible GenAI Adoption in Healthcare

Fractional AI, a leading provider of bespoke generative AI solutions, announced a new collaboration with Claritev, formerly known as MultiPlan. This coll...

June 26, 2025 | Thursday | News
3T Biosciences Boosts Cancer Target Discovery with INTEGRA’s Automated Liquid Handling Solutions

  INTEGRA Biosciences’ liquid handling solutions and pipette automation software are helping 3T Biosciences – a biotech company ba...

June 25, 2025 | Wednesday | News
Sanofi’s Riliprubart Secures FDA Orphan Drug Status for AMR in Transplants; Phase 2 Kidney Study Underway

Ongoing phase 2 study evaluating riliprubart for the potential prevention and treatment of active antibody-mediated rejection in kidney transplant reci...

June 25, 2025 | Wednesday | News
Novadip Biosciences Secures FDA RMAT Designation for NVD003 in Rare Pediatric Bone Disorder

Novadip Biosciences, a late-stage clinical biotechnology company specializing in regenerative medicine, announces that the FDA has granted the Regenerative...

June 24, 2025 | Tuesday | News
Nutriband and Kindeva Complete Commercial Manufacturing Scale-Up for AVERSA™ Fentanyl, Advancing World’s First Abuse-Deterrent Opioid Patch

Nutriband Inc.  a company engaged in the development of prescription transdermal pharmaceutical products, announced that it has completed commercial...

June 24, 2025 | Tuesday | News
Perceptive Discovery Launches FIBRE Consortium with Pfizer, Lantheus, and Lumina to Advance Imaging Biomarkers in Fibrotic Diseases

Perceptive Discovery, a global leader in molecular and functional imaging research, today announced the launch of the FIBRE (Fibrosis Imaging Biomarker R...

June 23, 2025 | Monday | News
Yale School of Medicine Launches Biomedical Imaging Institute to Drive Innovation in Health and Disease Research

Yale School of Medicine (YSM) announces the launch of the Yale Biomedical Imaging Institute, a cross-disciplinary hub that will unite leading experts in ...

June 23, 2025 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close